Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT01729806 · COMPLETED
Trial details
- NCT number
- NCT01729806
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-19
- Primary completion
- 2018-03-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.